Rafferty Asset Management, LLC Orchard Therapeutics PLC Transaction History

Rafferty Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$1.16 - $2.23 $756,328 - $1.45 Million	-652,007 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$2.24 - $4.29 $154,136 - $295,199	-68,811 Reduced 9.55%	652,007 $1.5 Million
Q2 2021 Aug 10, 2021	BUY	$4.39 - $7.23 $236,094 - $388,829	53,780 Added 8.06%	720,818 $3.16 Million
Q1 2021 May 10, 2021	BUY	$4.39 - $9.08 $2.51 Million - $5.18 Million	570,725 Added 592.57%	667,038 $4.84 Million
Q4 2020 Feb 10, 2021	BUY	$3.86 - $5.07 $371,768 - $488,306	96,313 New	96,313 $416,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.